BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 122415)

  • 1. Plasma prolactin-releasing factor-like activity in the amenorrhea-galactorrhea syndrome.
    Garthwaite TL; Hagen TC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):885-8. PubMed ID: 122415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolactin releasing activity in serum of pregnant women and patients with galactorrhea-amenorrhea syndrome].
    Takahashi K; Ikeno N; Minato K; Fukaya T; Momono K; Hoshiai H; Furuhashi N
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1479-86. PubMed ID: 7130769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea.
    Aono T; Shioji T; Miyai K; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variations of the plasma levels of gonadotrophins (FSH and LH) and of its response to stimulation with gonadotrophin releasing hormone (GnRH) with different plasma levels of prolactin (PRL) in women with the syndrome of galactorrhea-amenorrhea (author's transl)].
    Salmerón de Diego J; Alonso Rodríguez C; Santos Reyero M; Salazar Orlando A; Palacios Mateos JM
    Med Clin (Barc); 1981 Feb; 76(4):164-8. PubMed ID: 6782394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS].
    Imai T; Yasuda K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):1-15. PubMed ID: 3132404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of idiopathic hyperprolactinemia.
    Martin TL; Kim M; Malarkey WB
    J Clin Endocrinol Metab; 1985 May; 60(5):855-8. PubMed ID: 3980670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
    Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
    J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of pyridoxine on pituitary hormone secretion in amenorrhea-galactorrhea syndromes.
    Kidd GS; Dimond R; Kark JA; Whorton N; Vigersky RA
    J Clin Endocrinol Metab; 1982 Apr; 54(4):872-5. PubMed ID: 6801073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
    MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
    Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin-releasing and release-inhibiting factor activities in the bovine, rat, and human pineal gland: in vitro and in vivo studies.
    Blask DE; Vaughan MK; Reiter RJ; Johnson LY; Vaughan GM
    Endocrinology; 1976 Jul; 99(1):152-62. PubMed ID: 7446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms.
    Kapcala LP; Molitch ME; Arno J; King LW; Reichlin S; Wolpert SM
    J Endocrinol Invest; 1984 Oct; 7(5):455-60. PubMed ID: 6439770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome.
    Tucker HS; Lankford HV; Gardner DF; Blackard WG
    J Clin Endocrinol Metab; 1980 Nov; 51(5):968-71. PubMed ID: 6775003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gonadotropic functional state of the hypophysis in the galactorrhea-amenorrhea syndrome].
    Zhienkulova AK
    Probl Endokrinol (Mosk); 1982; 28(1):45-51. PubMed ID: 7199716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperprolactinemia in relation to galactorrhea and amenorrhea].
    Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):218-21. PubMed ID: 6426895
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin modulation of dehydroepiandrosterone sulfate secretion.
    Lobo RA; Kletzky OA; Kaptein EM; Goebelsmann U
    Am J Obstet Gynecol; 1980 Nov; 138(6):632-6. PubMed ID: 6449151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpuerperal lactation and normal prolactin regulation.
    Malarkey WB
    J Clin Endocrinol Metab; 1975 Feb; 40(2):198-204. PubMed ID: 1168856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.